Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study
Description
This study aims to assess the safety, virological, and clinical outcomes of convalescent plasma transfusion (CPT) in immunocompromised patients hospitalized for coronavirus disease 2019 (COVID-19). We conducted a retrospective multicenter cohort
